Nervous system

Farmak International works as a distributor of nervous system medications and a manufacturer of selected CNS therapies across neurology, psychiatry, and pain services. This model helps multi-site buyers in Europe qualify one CNS vendor as a CNS drug products distributor without fragmenting documentation across departments.

Nervous System Product Portfolio

Our anticonvulsant drugs include:

These anticonvulsant medications are supplied in pack-defined formats and kept stable within protocol.

The nervous system line includes olanzapine film-coated tablets and diazepam injection; the neurostimulants pharmaceutical line consists of citicoline, piracetam, and choline alfoscerate.

We also supply neurological analgesics B2B, including nefopam (tablets and injection), dexketoprofen (tablets, injection, sachets), paracetamol infusion, zolmitriptan (tablets and nasal spray), and pregabalin. They support pain management for neurological disorders from acute care to discharge.

Institutional Supply Applications

We support the nervous system supply in the following settings:

Each product entry is structured for internal evaluation (release form, strength, primary packaging, dossier type), and safety oversight continues after supply via an established pharmacovigilance function that monitors adverse events and supports reporting workflows. As a neuroprotective drugs manufacturer, we also keep batch traceability and controlled packaging inputs consistent for long-term therapy supply.

Product Specifications & Formulations

Our product list at https://farmak.com/products/ shows release form, strength, primary packaging, and dossier type per item, helping a nervous system medications distributor keep decisions concrete.

For long-term therapy, we supply standard oral forms: tablets, capsules, oral solutions, and unit-dose sachets. When rapid onset is required, we also work with injectable presentations such as ampoules, vials, and prefilled syringes, and we include nasal dosage forms where they are part of the clinical pathway.

As a neurostimulants pharmaceutical distributor, we keep strength and primary packaging defined at the item level for nootropic and neuroprotective products. Storage and stability follow the locally approved label, and temperature-sensitive routes are handled with cold-chain execution through qualified forwarding partners.

Quality Assurance & Regulatory Compliance

Farmak International operates under a quality framework supported by audits and certifications from national authorities (including Ukraine, Poland, and Croatia) and the World Health Organization.

We adhere to European Medicines Agency (EMA) requirements and structure our documentation in accordance with internationally recognized regulatory standards:

As a neuroprotective drugs manufacturer, we apply Good Manufacturing Practice (GMP) discipline across materials, finished medicines, and packaging control. Pharmacovigilance remains part of supply: we monitor product safety evaluate reported adverse effects, and implement corrective and preventive actions in accordance with regulatory requirements.

For controlled psychiatric medicines, storage and handling follow the locally approved labeling and the applicable national legal frameworks. On the supply side, we support compliant handoffs with country-specific labeling, multilingual patient information, and logistics controls appropriate for medical products, including temperature-controlled execution when required by route or product conditions.

Partnership with Farmak for Nervous System Product Supply

Across Europe, we support long-term institutional agreements with defined documentation standards, predictable availability., and regulatory support for tenders and international submissions. If you are qualifying a neurological drugs distributor or a neurodegenerative disease treatments supplier, send Farmak International your target country and shortlist so we can confirm dossier format, lead times, and distribution conditions that protect neurological health.

To start, share the target country, expected annual volume, and whether temperature-controlled routing is required. We will respond with a practical neurological health supply plan and the documentation set for your review.